Laurie Fenton Ambrose
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Laurie Fenton Ambrose
Jul 25, 2024, 01:13 |
Blog
Drew Moghanaki: GO2 for Lung Cancer ensuring access to high-quality lung cancer screening for Veterans at risk
Drew Moghanaki shared a post on X: "Thank you, GO2 for Lung Cancer for your…
May 19, 2024, 10:49 |
Societies
Laurie Fenton Ambrose explains breakthrough advance in extensive-stage small cell lung cancer - Amgen Oncology
Amgen Oncology shared on LinkedIn: “A breakthrough advance in extensive-stage small cell lung cancer (ES-SCLC)…
May 3, 2024, 11:44 |
Blog
Laurie Fenton Ambrose: About the launch of the INHERIT study
Neal Augenstein, Reporter at WTOP, shared a post by Laurie Fenton Ambrose, President and CEO of…
Dec 10, 2023, 17:26 |
Career
Mark Awad was honored by GO2 for Lung Cancer at the 18th Annual Simply the Best Gala - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute posted on LinkedIn: "Congratulations to Mark Awad, MD, PhD who was honored…
All:
4
Posts:
1 - 100
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Our commitment to seek all possible pathways to make BOT/BAL available to patients is unwavering: Steven O'Day, Agenus CMO
Facebook
RSS Feed
Twitter
Linkedin
Youtube